# CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/CRMD/cormedix-therapeutics-to-participate-in-the-wells-fargo-healthcare-conference-28ce6f69
Ticker: CRMD
Company: CorMedix Inc.
Source: CorMedix Inc.
Published: 2026-09-01 12:30 EST
## Summary

CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...

## Article Body
CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that senior management will be participating in a fireside chat and investor meetings at the upcoming Wells Fargo 21st Annual Healthcare Conference being held in Boston on September 8 – 10, 2026.

| Wells Fargo 21st Annual Healthcare Conference |  |
| --- | --- |
| Date: Time: Webcast: | Wednesday, September 9, 2026 12:45pm EDT Click here |

A replay of the fireside chat will also be available in the “Presentations and Events” page on the investor relations portion of the Company’s website at: www.cormedix.com

About CorMedix CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases in the United States. CorMedix is focused on selling and marketing products in institutional settings of care in the US and has field based medical and commercial infrastructure deployed in hospitals, clinics and infusion centers. For more information visit: www.cormedix.com .

Investor Contact: Dan Ferry Managing Director LifeSci Advisors daniel@lifesciadvisors.com (617) 430-7576
## Recent Company News
- 2026-09-01 12:30 EST — [CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference](https://biopharmsignal.com/news/CRMD/cormedix-therapeutics-to-participate-in-the-wells-fargo-healthcare-conference-28ce6f69) — Source: CorMedix Inc.
- 2026-08-13 11:30 EST — [Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update](https://biopharmsignal.com/news/CRMD/cormedix-therapeutics-reports-second-quarter-2026-financial-results-and-provides-3ba49a14) — Source: CorMedix Inc.
- 2026-07-29 12:30 EST — [CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026](https://biopharmsignal.com/news/CRMD/cormedix-therapeutics-to-report-second-quarter-2026-financial-results-and-provid-d049bf35) — Source: CorMedix Inc.
- 2026-06-08 12:30 EST — [U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation](https://biopharmsignal.com/news/CRMD/u-s-court-of-appeals-for-the-federal-circuit-affirms-victory-for-cormedix-therap-ae49f299) — Source: CorMedix Inc.
- 2026-05-15 12:30 EST — [Cormedix Therapeutics to Participate in two Upcoming Investor Conferences](https://biopharmsignal.com/news/CRMD/cormedix-therapeutics-to-participate-in-two-upcoming-investor-conferences-ec428c77) — Source: CorMedix Inc.
## Related News
- 2026-09-04 20:30 EST — ORIC — [ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/ORIC/oric-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c--e23953dd)
- 2026-09-04 20:05 EST — RPID — [Rapid Micro Biosystems to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/RPID/rapid-micro-biosystems-to-participate-in-upcoming-investor-conferences-91a8800f)
- 2026-09-04 20:05 EST — LIXT — [NOMAD POWER SOLUTIONS ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS](https://biopharmsignal.com/news/LIXT/nomad-power-solutions-announces-adjournment-of-special-meeting-of-stockholders-74cd9e2e)
- 2026-09-04 20:05 EST — AVTX — [Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/AVTX/avalo-therapeutics-announces-inducement-grants-to-new-employees-under-nasdaq-lis-cc7baaf2)
- 2026-09-04 20:05 EST — NTLA — [Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/NTLA/intellia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-250d5dd9)